I'll check the FDA site tonight
Botanix Pharmaceuticals' (BOT) lead product, Sofpironium Bromide, had passed a US Food and Drug Administration (FDA) mid-cycle review. The company said the FDA detected no safety or risk management issues in the review of the Botanix product.
last mention
Ann: Trading Halt, page-20
-
- There are more pages in this discussion • 297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $597.3M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.3¢ | $1.265M | 3.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 129446 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 131308 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |